Azitra (AZTR) Non Operating Income (2022 - 2026)
Azitra (AZTR) reported Non Operating Income of -$4624.0 for Q1 2026, down 12.21% on a YoY basis from -$5266.9 in Q1 2025, and up 92.49% quarter-over-quarter from -$61597.0 in Q4 2025.
Azitra (AZTR) Non Operating Income (2022 - 2026) Analysis & Trends
Azitra has reported Non Operating Income for 5 years, with the latest figure at -$4624.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 12.21% year-over-year to -$4624.0; the trailing twelve-month figure through Mar 2026 stood at -$99537.0 (up 94.89% YoY), and the FY2025 full-year result was -$43389.0, down 388.99% from the prior year.
- Non Operating Income for Q1 2026 stood at -$4624.0, up from -$61597.0 in the prior quarter.
- The five-year high for Non Operating Income was $3.8 million in Q4 2023, with the low at -$2.0 million in Q4 2024.
- Historically, Non Operating Income has averaged $50485.1 across 5 years, with a median of -$2902.0 in 2023.
- Annual changes were most pronounced in 2024 — Non Operating Income surged 697.29% — and 2025, when it tumbled 443.04%.
- Azitra's Non Operating Income stood at -$1.2 million in 2022, then surged by 420.43% to $3.8 million in 2023, then plunged by 151.82% to -$2.0 million in 2024, then surged by 96.86% to -$61597.0 in 2025, then soared by 92.49% to -$4624.0 in 2026.
- The last three Non Operating Income figures came in at -$4624.0 (Q1 2026), -$61597.0 (Q4 2025), and -$628.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | -4,624.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,624.00 |
| Dec 31, 2025 | -61,597.00 |
| Sep 30, 2025 | -628.00 |
| Jun 30, 2025 | -32,688.00 |
| Mar 31, 2025 | -4,121.00 |
| Dec 31, 2024 | -1.96 Mn |
| Sep 30, 2024 | 7,509.00 |
| Jun 30, 2024 | 9,529.00 |
| Mar 31, 2024 | 28,622.00 |
| Dec 31, 2023 | 3.79 Mn |
| Sep 30, 2023 | 50,443.00 |
| Jun 30, 2023 | -1,683.00 |
| Mar 31, 2023 | -4,792.00 |
| Dec 31, 2022 | -1.18 Mn |
| Sep 30, 2022 | -19,038.00 |
| Jun 30, 2022 | 198,234.00 |